Journal of General Internal Medicine

, 24:1183

Influence of Patient Race on Physician Prescribing Decisions: A Randomized On-Line Experiment

  • Saif S. Rathore
  • Jonathan D. Ketcham
  • G. Caleb Alexander
  • Andrew J. Epstein
Original Article

DOI: 10.1007/s11606-009-1077-7

Cite this article as:
Rathore, S.S., Ketcham, J.D., Alexander, G.C. et al. J GEN INTERN MED (2009) 24: 1183. doi:10.1007/s11606-009-1077-7

ABSTRACT

BACKGROUND

Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes.

OBJECTIVE

To assess whether patient race influences physicians’ prescribing.

DESIGN

Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes.

SUBJECTS

A total of 716 respondents from 5,141 eligible sampled primary care physicians (14% response rate).

INTERVENTIONS

None

MEASUREMENTS

Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians’ treatment adherence forecast (10-point Likert scale, 1—definitely not adhere, 10—definitely adhere).

RESULTS

Respondents randomized to view black patients (n = 371) and white patients (n = 345) recommend any medications at comparable rates for hypercholesterolemia (100.0% white vs 99.5% black, P = 0.50), hypertension (99.7% white vs 99.5% black, P = 1.00), and diabetes (99.7% white vs 99.7% black, P = 1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors less often (47.4% black vs 62.6% white) (P < 0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P < 0.001, mean: 7.3 black vs 7.7 white) and diabetes (P = 0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P = 0.15, mean: 7.2 black vs 7.3 white).

CONCLUSION

Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.

KEY WORDS

patient raceprescription medicationhypertensionhypercholesterolemiadiabetes

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  • Saif S. Rathore
    • 1
  • Jonathan D. Ketcham
    • 2
  • G. Caleb Alexander
    • 3
    • 4
    • 5
    • 6
  • Andrew J. Epstein
    • 7
    • 8
  1. 1.MD/PhD Program, SHM IE-61Yale University School of MedicineNew HavenUSA
  2. 2.W.P. Carey School of BusinessArizona State UniversityTempeUSA
  3. 3.Center for Health and Social SciencesUniversity of ChicagoChicagoUSA
  4. 4.General Internal Medicine Section, Department of MedicineUniversity of ChicagoChicagoUSA
  5. 5.MacLean Center for Clinical Medical EthicsUniversity of ChicagoChicagoUSA
  6. 6.Department of Pharmacy PracticeUniversity of Illinois at Chicago School of PharmacyChicagoUSA
  7. 7.Section of Health Policy and Administration, Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA
  8. 8.Leonard Davis Institute of Health EconomicsUniversity of PennsylvaniaPhiladelphiaUSA